Faron, etusivu

releases and announcements

Proposed Placing and Subscription

Regulatory

Traumakine Receives PIM Designation from MHRA

Regulatory

Directors Dealings

Insider Transaction Regulatory

Interim Results

Regulatory

FDA advises Faron to proceed directly to BLA

Regulatory

Update on INTEREST Phase III Study from IDMC

Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Holding(s) in Company

Shareholder announcement Regulatory

Notice of Results

Regulatory

Director/PDMR Shareholding

Insider Transaction Regulatory
PreviousNext
Back to top